Madeline Pendley is an attorney at Levin Papantonio and works on several litigations including AFFF, Valsartan, and Zantac. She graduated from the University of North Georgia with a Bachelor of Arts in Political Science. She then received her Juris Doctorate from Stetson College of Law where she served on Stetson’s Law Review, as well as Stetson’s Nationally Ranked Trial Team. She competed in two regional and four national competitions, and was named ‘Captain’ and ‘Most Valuable Player’ of the team.
Since joining Levin Papantonio, she has since been appointed to various MDL committees, including the Losartan and Irbesartan committee, Zantac Leadership and Development Committee, and the Valsartan Plaintiff’s Steering Committee.
Year Joined the Firm
2019
Present Position with the Firm
Attorney
Areas of Practice
Mass Tort Litigation
Product Liability
Environmental
Bar Admissions
Florida
Education
Juris Doctor, Stetson University College of Law
Bachelor of Science, University of North Georgia
Professional Associations and Memberships:
American Association for Justice (AAJ ), member
Florida Justice Association, member
The National Trial Lawyers, Top 40 Under 40
Seminars Taught and Published Works
Mass Torts Made Perfect, “New Valsartan Criteria: How to Vet and Score Cases,” October 2019.
National Trial Lawyer’s Summit, “Zantac & Valsartan: NDMA Contamination,” January 2020.
“Zantac: The Blockbuster Carcinogen,” Journal of the Florida Justice Association (March/April 2020).
“Zantac Litigation Starts to Gain Steam,” the Trial Lawyer Magazine (June 2020).
Mass Torts Made Perfect. “Zantac Litigation,” October 2020.
